1. Wang, Y., Y. Li, G. Wang, J. Lu and Z. Li, 2023. Overexpression of Homer1b/c induces valproic acid resistance in epilepsy. CNS Neurosci. Ther., 29: 331-343.
   CrossRef  |  Direct Link  |  
2. Wang, Y., C. Li, Z. Xiong, N. Chen and X. Wang et al., 2022. Up-and-coming anti-epileptic effect of aloesone in Aloe vera: Evidenced by integrating network pharmacological analysis, in vitro, and in vivo models. Front. Pharmacol., Vol. 13. 10.3389/fphar.2022.962223.
   CrossRef  |  Direct Link  |  
3. Wang, Y., W. Hu and Z. Li, 2020. Influence of age and co-medication on the concentration and efficacy of valproic acid in Chinese epilepsy children. Pak. J. Pharm. Sci., 33: 537-542.
   CrossRef  |  Direct Link  |  
4. Wang, Y., G. Wang, J. Tao, X. Li and L. Hu et al., 2020. Autophagy associated with the efficacy of valproic acid in PTZ-induced epileptic rats. Brain Res., Vol. 1745. 10.1016/j.brainres.2020.146923.
   CrossRef  |  Direct Link  |  
5. Wang, Y. and Z. Li, 2020. Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy. Therapies, 75: 261-270.
   CrossRef  |  Direct Link  |  
6. Wang, Y. and Z. Li, 2019. RNA-seq analysis of blood of valproic acid‑responsive and non-responsive pediatric patients with epilepsy. Exp. Ther. Med., 18: 373-383.
   CrossRef  |  Direct Link  |  
7. Wang, Y. and Z. Li, 2017. CYP3A5*3 polymorphism may influence the concentration of valproic acid. Int. J. Pharmacol., 13: 495-500.
   CrossRef  |  Direct Link  |  
8. Wang, Y. and Z. Li, 2016. Utilization of antiepileptic drugs on monotherapy and polytherapy for children at Shanghai in China. Int. J. Pharmacol., 12: 496-504.
   CrossRef  |  Direct Link  |  
9. Wang, Y., H. Hu, M. Zhao, J. Zhao and D. Yin et al., 2013. Nonylphenol disrupts the cardio-protective effects of 17β-estradiol on ischemia/reperfusion injury in isolated hearts of guinea pig. J. Toxicol. Sci., 38: 731-740.
   CrossRef  |  Direct Link  |